ProShare Advisors LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 75 filers reported holding HUMACYTE INC in Q2 2023. The put-call ratio across all filers is 45.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$43,121
+2.9%
14,717
+0.5%
0.00%
Q2 2023$41,899
-3.6%
14,650
+4.1%
0.00%
Q1 2023$43,470
+28.0%
14,068
-12.6%
0.00%
Q4 2022$33,956
-0.1%
16,093
+51.7%
0.00%
Q3 2022$34,000
+6.2%
10,610
+6.1%
0.00%
Q2 2022$32,000
-57.3%
10,004
-6.2%
0.00%
Q1 2022$75,000
-28.6%
10,660
-26.5%
0.00%
Q4 2021$105,00014,5060.00%
Other shareholders
HUMACYTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders